2008•Cancer Treatment ReviewsRequires access

Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR

Volker Heinemann, Sebastian Stintzing, Thomas W. Kirchner, Stefan Hubert Boeck, Andreas Jung

Open publisher page 207 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 207 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: KRAS, Cetuximab, Medicine, Panitumumab, PTEN, Epidermal growth factor receptor, Colorectal cancer, Oncology

Back to paper search Browse research topics Original source

Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR — Research Paper | ScholarLens